According to the Department of Health and Human Services (HHS), over 7 million Americans have received the updated COVID-19 vaccine since its approval one month ago. The Pfizer and Moderna shots were approved by the Food and Drug Administration (FDA) on September 11, and distribution was authorized by the Centers for Disease Control and Prevention …
The Department of Health and Human Services (HHS) has announced a new agreement with Pfizer that ensures continued access to the antiviral medication Paxlovid for the next few years. This agreement comes as the drug is being prepared for transition into the commercial market. HHS emphasized that this agreement aims to maximize the investment made …
The Food and Drug Administration decided not to approve Neffy, an epinephrine nasal spray developed by ARS Pharmaceuticals, which means that the first needle-free option for treating severe allergic reactions won’t be available to the American market until more trial data is gathered. ARS had anticipated the FDA’s approval for Neffy’s use in adults and …
The label for the diabetes drug Ozempic — which has gained popularity for weight loss — now acknowledges reports of blocked intestines following use of the medication. The change comes after the Food and Drug Administration greenlighted a series of updates from drugmaker Novo Nordisk for its product. Ozempic now joins other products in this …
The Centers for Disease Control and Prevention on Friday recommended a new Pfizer vaccine to protect newborn babies from respiratory syncytial virus, commonly known as RSV. File Photo by Bill Greenblatt/UPI | License Photo Sept. 23 (UPI) — The Centers for Disease Control and Prevention have made a significant recommendation to safeguard newborn babies from …
The Centers for Disease Control and Prevention on Friday recommended a new Pfizer vaccine to protect newborn babies from respiratory syncytial virus, commonly known as RSV. File Photo by Bill Greenblatt/UPI | License Photo Sept. 23 (UPI) — The Centers for Disease Control and Prevention has made a recommendation for a new Pfizer vaccine that …
By Jonel Aleccia The Associated Press Posted September 20, 2023 6:43 pm Descrease article font size Increase article font size Federal regulators declined to approve a nasal spray to treat severe allergic reactions late Tuesday, calling for more research on what would have been the first alternative to injections using devices such as an EpiPen. …
The U.S. Food and Drug Administration has requested further studies by ARS Pharmaceuticals on its neffy treatment before it will approve its use. Photo courtesy of ARS /Website Sept. 20 (UPI) — Federal regulators have declined to approve the first needle-free epinephrine treatment for people who suffer from severe allergic reactions, requesting its developer, ARS …
The U.S. Centers for Disease Control and Prevention Recommends COVID-19 Booster Shot for All Americans Sept. 13 (UPI) – In preparation for the winter season, the U.S. Centers for Disease Control and Prevention (CDC) is advising all Americans, including those as young as 6 months old, to receive the updated COVID-19 booster shot, which will …
The Ineffectiveness of Phenylephrine in Decongestants Government experts have determined that the leading decongestant used by millions of Americans, which contains phenylephrine, offers no relief for a stuffy nose. The drug ingredient has long been questioned for its effectiveness, and advisers to the Food and Drug Administration (FDA) unanimously voted against it. Dr. Mark Dykewicz, …